Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis

OBJECTIVES: Cancer cachexia (CCA) is an intractable and ineffective metabolic syndrome that attacks 50–80% of cancer patients. It reduces patient's life quality, affects the efficacy of treatment, and then increases their mortality; however, there are no established therapeutic strategies for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Wang, Yanling, Tong, Mengting, Pan, Hongming, Li, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612387/
https://www.ncbi.nlm.nih.gov/pubmed/31341892
http://dx.doi.org/10.1155/2019/2864384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612387/
https://www.ncbi.nlm.nih.gov/pubmed/31341892
http://dx.doi.org/10.1155/2019/2864384

Ejemplares similares